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Background: Both physical therapy (PT) and surgery are effective in treating femoroacetabular impingement (FAI), but their relative
efficacy has not been well established until recently. Several randomized controlled trials (RCTs) comparing the early clinical
outcomes of these treatments have been published, with contradictory results.
Purpose/Hypothesis: The purpose of this study was to perform a meta-analysis of RCTs that compared early patient-reported
outcomes (PROs) of hip arthroscopy versus PT in patients with symptomatic FAI. The hypothesis was that surgical treatment of FAI
leads to better short-term outcomes than PT.
Study Design: Systematic review; Level of evidence, 1.
Methods: In March 2019, a systematic review was performed to identify RCTs comparing hip arthroscopy and PT in
patients with symptomatic FAI. A total of 819 studies were found among 6 databases; of these, 3 RCTs met eligibility
(Griffin et al, 2018; Mansell et al, 2018; and Palmer et al, 2019). All 3 RCTs reported international Hip Outcome Tool–33
(iHOT-33) scores, and 2 reported Hip Outcome Score (HOS)–Activities of Daily Living (ADL) and HOS-Sport results.
In a random-effects meta-analysis, between-group differences in postintervention scores were assessed according to
intention-to-treat and as-treated approaches. Quality was assessed with CONSORT, CERT, TiDieR, and the Cochrane
Collaboration tool.
Results: The 3 RCTs included 650 patients with FAI; the mean follow-up ranged from 8 to 24 months. All studies reported
PRO improvement from baseline to follow-up for both PT and surgery. The quality of the Griffin and Palmer studies was
good, with minimal bias. In the Mansell study, a 70% crossover rate from PT to surgery increased the risk of bias. The meta-
analysis demonstrated improved iHOT-33 outcomes with surgery compared with PT for intention-to-treat (mean difference
[MD], 11.3; P ¼ .046) and as-treated (MD, 12.6; P ¼ .007) analyses. The as-treated meta-analysis of HOS-ADL scores
favored surgery (MD, 12.0; P < .001), whereas the intention-to-treat analysis demonstrated no significant difference between
groups for HOS-ADL (MD, 3.9; P ¼ .571).
Conclusion: In patients with FAI, the combined results of 3 RCTs demonstrated superior short-term outcomes for surgery versus
PT. However, PT did result in improved outcomes and did not appear to compromise the surgical outcomes of patients for whom
therapy failed and who progressed to surgery.
Keywords: randomized controlled trials; femoroacetabular impingement; hip arthroscopy; physical therapy
Femoroacetabular impingement (FAI) syndrome is increas-
ingly recognized and treated in adolescent and young adult
patients.2 A number of surgical studies have demonstrated
patient improvements after surgical treatment of FAI.
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However, some patients have suboptimal outcomes, with
18% to 34% not reaching minimal clinically important dif-
ference (MCID) thresholds for patient-reported outcomes
(PROs).16 Physical therapy (PT) that emphasizes strength-
ening, motor control, and movement patterns, rather than
range of motion, appears to relieve pain in some patients
with FAI.27 The success rates of nonoperative treatment for
FAI have ranged from 39% to 82%.13,20 Rigorous compara-
tive research between outcomes of PT and FAI surgery has
been previously lacking. The National Institutes of Health–
sponsored American Academy of Orthopaedic Surgeons/
Orthopaedic Research Society (AAOS/ORS) FAI Research
Symposium of international leaders in 2012 concluded, “an
urgent need exists for a randomized clinical trial that could
compare the surgical and nonsurgical management of
symptomatic FAI to justify definitively the need for surgical
intervention in these patients.”3
Several randomized controlled trials (RCTs) have
recently been completed and published on this topic;
however, the results are contradictory. It is important
to systematically assess the findings and quality of these
RCTs in order to reach a conclusion on the best evidence
on this topic. The purpose of the current study was to
perform a systematic review and meta-analysis of RCTs
that directly compared the short-term outcomes of PT
and surgery in patients with symptomatic FAI. The
study hypothesis was that surgical treatment of FAI
leads to better short-term outcomes, as measured by the
international Hip Outcome Tool-33 (iHOT-33), compared
with PT.
METHODS
A systematic review and meta-analysis of RCTs comparing
PT and surgery in patients with FAI was performed using
the PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines. The question
inquired was, “Is there a difference in patient-reported out-
comes of patients with femoroacetabular dysplasia
impingement who have surgery versus conservative man-
agement with physical therapy?”
Eligibility Criteria
The inclusion criteria consisted of RCTs comparing the
surgical and nonsurgical management of patients with
FAI. Exclusion criteria included studies that did not
assess FAI, were not randomized, did not compare sur-
gical and nonsurgical interventions, and did not assess
human patients. Additional exclusion criteria were stud-
ies in a language other than English, duplicates, proto-
col/feasibility studies, abstracts, and reviews/case
studies/commentaries.
Search Strategy
A search of the literature was performed with the assis-
tance of a medical librarian with extensive experience in
systematic reviews and included the search terms
“femoroacetabular impingement” and “randomized con-
trolled trials,” with similar keywords; an RCT filter was
used. The databases searched were Ovid Medline 1946-,
Embase 1947-, Scopus 1960-, Cochrane Central Register
of Controlled Trials, Cochrane Database of Systematic
Reviews, and ClinicalTrials.gov. These databases were
employed to ensure that a broad and exhaustive search
was performed. In total, 819 results were exported and
340 duplicates were removed, resulting in 479 final cita-
tions for review. The search was performed on March 1,
2019; complete search strategies are contained in
Appendix 1.
Study Selection and Data Collection
Two reviewers (M.T.S. and A.L.C.) were blinded and inde-
pendently reviewed all abstracts and relevant articles, and
discrepancies regarding eligibility were resolved by discus-
sion between the 2 reviewers. Then, each reviewer indepen-
dently performed the data extraction, of which the
variables included author, year, setting, patient character-
istics, number of surgeons and therapists, type of surgery
and therapy, expertise, randomization method, percentage
receiving allocating treatment, crossover, and PROs. The
CONSORT (Consolidated Standards of Reporting Trials)
checklist22 was used to ensure that each study met the
evidence-based, minimum set of requirements. Overall risk
of bias among the studies was assessed using the Cochrane
Collaboration tool.11 To assess the reporting of the PT and
surgical treatment, the TIDieR (Template for Intervention
Description and Replication) checklist12 was utilized. Addi-
tionally, for PT we used the CERT (Consensus on Exercise
Reporting Template) guidelines23 specifically to assist in
scoring items 4 (what: procedures) and 8 (when and how
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much) in the TIDieR checklist. See Appendix 2 for further
methodological details.
A total of 3 studies (Griffin et al [2018],8 Mansell et al
[2018],15 and Palmer et al [2019]19) met all eligibility crite-
ria, as summarized in Figure 1. The published protocols (all
3 studies) and feasibility publications (Griffin and Palmer
studies) were assessed for additional details not present in
the primary papers.7,9,14,17,18 As the effect size and stan-
dard deviation of iHOT-33 noted in the Palmer study did
not appear to be possible as reported, the authors of the
Palmer study were contacted and the correct data were
provided (Sion Glyn-Jones, personal communication,
2019). The previously reported iHOT-33 effect size of 2.0
(95% CI, 1.3-2.8) was corrected to the actual result of 20
(95% CI, 13-28) and utilized in the analysis.
Outcome Measures and Analysis
Similar PROs across the studies included the iHOT-33 (all
studies8,15,19), Hip Outcome Score (HOS)–Activities of Daily
Living (ADL) subscale (2 studies15,19), and HOS-Sport sub-
scale (2 studies15,19) and were utilized for meta-analysis. The
iHOT-33 was used as the primary outcome because all 3
studies included this value, and the HOS was used as a sec-
ondary outcome. Follow-up was based on time from
randomization to final outcome, not when treatment (surgery
or PT) was actually received. All studies reported the differ-
ence in final scores between the 2 treatment groups at follow-
up. Todetermine significant clinical improvement, the3stud-
ies used the MCID. Only the Palmer study used the Patient
Acceptable Symptomatic State (PASS), and no studies used
the substantial clinical benefit. A pre- to posttreatment effect
size of PT and surgery could not be measured with the avail-
able data from the publications; thus, a similar baseline score
was assumed given randomization, and the final posttreat-
ment score was the primary outcome.
A meta-analysis was performed across the 3 RCTs after
detailed assessments of each study. A Cochrane Q and I2
were calculated to assess statistical heterogeneity. Each
meta-analysis had high heterogeneity, as seen by the
I2 values, likely from the variability in PT protocol, patient
population, and crossover bias. Because of the heterogene-
ity in patient populations, all assessments were done with a
random-effects model, and a standardized mean difference
(MD) was obtained. While some differences in patient popu-
lation, PT intervention, and surgical intervention were
present across studies, our multidisciplinary team judged
them to be adequately representative of the current treat-
ment of FAI to allow meta-analysis.
Given the large crossover rate present in 1 study15 (70%
crossover PT to surgery), which may significantly bias
intention-to-treat analyses, both intention-to-treat and as-
treated analyseswereperformed.Dataforas-treated analyses
were available for 2 studies.8,15 No as-treated analysis data
were available for the Palmer19 study, but given the low rateof
crossover present in this study, intention-to-treat data from
the Palmer study were combined into the as-treated meta-
analysis.
RESULTS
A total of 650 patients were included in the 3 RCTs evalu-
ated in the meta-analysis.8,15,19 The Palmer19 and Griffin8
studies were multicenter trials, while the Mansell15 study
was a single-institution trial. The 3 studies differed in their
calculated sample size to achieve appropriate power
(Table 1). The Mansell study was performed in a US mili-
tary population (1 surgeon, 80 patients), while the Griffin
and Palmer studies were performed in civilian UK popula-
tion (27 surgeons, 348 patients; and 10 surgeons,
222 patients, respectively) (Tables 1 and 2). The Griffin
study included patients who had received PT before enroll-
ment, while the Mansell study included patients who had
participated in a self-management program before enroll-
ment. The percentage of eligible patients enrolled was 63%
for the Palmer study, 54% for the Griffin study, and 77% for
the Mansell study. Each study used a computer-generated
randomization method (1:1 allocation for the Palmer and
Griffin studies, blocks of 2 or 4, with a 1:1 ratio for the
Mansell study). All studies designated intention-to-treat
analyses as the primary outcome, but Griffin and Mansell
also reported as-treated analyses. Overall, follow-up was
good for each study, ranging from 85% to 93% (78% reach-
ing the 2-year time point for the Mansell study) (Table 2).
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Figure 1. PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) flow diagram of included stud-
ies. FAI, femoroacetabular impingement.
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Risk of Bias
The quality of 2 RCTs (Griffin and Palmer studies) was
assessed as good, with minimal bias, while in the third RCT
(Mansell study), several study characteristics increased the
risk of bias (Table 3). First, an extremely high crossover
rate may have affected interpretability of the Mansell study
results (70% crossover from PT to surgery). The mean time
to surgery was only 71.4 days longer in patients crossing
over (compared with randomization to surgery) in this
study. This resulted in the comparison of groups receiving
surgery (95% vs 70%) in the intention-to-treat analyses for
the Mansell study, which results in large differences
between the intention-to-treat and as-treated analyses for
HOS-ADL for this study. Additional risks of bias in the
Mansell study included the single-center design, unique
(military) population, notably different PT protocol com-
pared with the other 2 studies (including exercises that
moved the hip into an impingement position), and a smaller
sample size compared with the other 2 studies.
The other 2 studies had low crossover rates from PT to
surgery (Griffin8 study, 8%; Palmer19 study, 5%). Surgery
was completed in 84% (Griffin study), 88% (Palmer study),
and 95% (Mansell15 study) of patients allocated to the
surgery group. In the Palmer study, 9% of patients received
incomplete surgical treatment (labral treatment only with-
out bony correction because of advanced osteoarthritis)
because they would be at higher risk for a poor outcome.
All studies had significant wait times from randomization
to actual surgery, with most patients obtaining surgery at
about 3 months postrandomization, while short-term out-
comes were still assessed relative to time of randomization.
Last, all studies were unable to blind participants and per-
sonnel to the intervention type because no sham procedures
were performed.
Qualitative Assessment
The assessment of TIDieR and CERT for each study is pro-
vided in Appendix 2.
Physical Therapy. Based on our review, no trial achieved
100% reporting PT details based on TIDieR. The Griffin8
study scored the highest, with 67%, while the Palmer19 and
Mansell15 studies each scored 33%. All studies used a mul-
timodal approach to physical therapist–led intervention.
Intervention described in all 3 studies was based on a sys-
tematic review26 or consensus of an expert panel. The Man-
sell study described their intervention as standard of care.
TABLE 1
Study Characteristicsa
Study Setting Sample Size Surgeons/PTs, n PT Visits
Palmer et al (2019)19 7 centers in the United Kingdom 222 10/2 8 sessions over 20 weeks
Griffin et al (2018)8 23 centers in the United Kingdom 348 27/47 6-10 sessions over 12-24 weeks
Mansell et al (2018)15 Army medical center in the United States 80 1/1 12 sessions over 6 weeks
aPT, physical therapy.
TABLE 2
Study Methods and Patient Characteristicsa
Study
Male Sex,
n (%)
Age, y,
Mean ± SD Analysis
Follow-up
Length Follow-up, %
% Receiving
Allocated
Treatment PT Visits Surgery Details: %
Palmer et al
(2019)19
75 (34) 36.2 ± 9.7 ITT 8 mo 85 PT—83
Surgery—88
8 sessions over
20 wk
Labral repair: 70
Labral debridement: 25
No labral treatment: 4
Femoral osteoplasty: 86
Acetabular rim trimming: 25
Acetabular microfracture: 9
Griffin et al
(2018)8
213 (61) 35.3 ± 9.6 ITT 1 y 92 PT—95
Surgery—84
6-10 sessions
over 12-24 wk
Labral repair: 25
Labral debridement: 60
Labral resection: 5
Femoral osteoplasty: 92
Acetabular rim trimming: 24
Acetabular microfracture: 15
Acetabular chondroplasty: 27
Mansell et al
(2018)15
47 (59) 30.1 ± 7.4 ITT 2 yb 93 PT—28
Surgery—95
12 sessions
over 6 wk
Surgical details not provided
aITT, intention to treat; PT, physical therapy.
bA total of 78% with available 2-year patient-reported outcome.
4 Schwabe et al The Orthopaedic Journal of Sports Medicine
The studies utilized 1 to 47 physical therapists (Table 1).
Despite referencing the same evidence, the PT interven-
tions used across studies were quite varied. All studies used
both supervised sessions in a PT clinic and a home exercise
program that included core components of hip muscle
strengthening and neuromuscular control exercises. Two
of the 3 studies (by reported protocol) included the following
core components: flexibility,7,14 core stability,7,17 and edu-
cation to avoid the impingement position.7,17 Additional
core components included hip joint mobilization,14 lumbar
mobility,14 and instruction in activity modification and
physical activity.7 All studies allowed for individualization
based on pain and movement impairments. Across studies,
the planned PT treatment dosage varied: 8 visits over 5
months,19 6 to 10 visits over 6 months,8 and 12 visits over
6 weeks.15
FAI Surgery. FAI surgery was performed via hip
arthroscopy in all studies. The number of surgeons
included 1,15 10,19 and 278 surgeons, all with some level
of expertise in hip arthroscopy (performed at least 100
arthroscopies annually or at least had “extensive experi-
ence”). Hip arthroscopy for each study also included bony
correction or labral treatments as deemed appropriate. Pre-
operative radiographic definitions of FAI morphology were
present (cam, pincer, and mixed), and clinical examination
helped support the findings. No studies included data
regarding the adequacy of bony correction. Only the Grif-
fin8 study utilized a panel of experts to assess the quality of
surgical care (87% deemed high fidelity, 13% inadequate).
Postoperative PT was utilized in all studies, with similar
limitations in the level of detail to the nonsurgical treat-
ment PT arm described above.
Complications and Reoperations
Based on intention to treat, the surgery group’s complica-
tion rate in the Mansell15 study was 2.5% (1 heterotopic
ossification) and the reoperation rate was 2.6% (1 hip
arthroplasty), compared with a 2.5% complication rate
(1 fracture after crossover to surgery) and 12.5% reopera-
tion rate (5 revision hip surgeries) for the PT group. Accord-
ing to as-treated analysis, the complication rate of surgery
was 3.0% (1 heterotopic ossification, 1 hip fracture) and the
reoperation rate was 9.2% (1 hip arthroplasty). The
Palmer19 study reported a 3% rate of nonserious
complications (0% serious complications), including a
superficial wound infection treated with oral antibiotics
and temporary lateral femoral cutaneous neurapraxia. The
Palmer study reported no reoperations, but the study had a
short-term follow-up. The Griffin8 study reported minor
complications of surgery in 7.9% (9 superficial wound infec-
tion, 2 thigh numbness), while serious complications were
present in 0.7% (1 hip infection leading to total hip arthro-
plasty). To allow comparability across studies, we did not
include some complications in this comparison (that were
noted in the studies), including contralateral hip surgery
(Mansell study intention-to-treat/as-treated: 0/6 surgery, 6/
0 PT), hip osteoarthritis without reoperation (Mansell
study intention-to-treat/as-treated: 5/7 surgery, 3/1 PT),
muscle soreness or spasms (Griffin study: 58 surgery, 70
PT), hip pain or stiffness (Griffin study: 13 surgery, 8 PT),
unscheduled hospital appointments (Griffin study: 13 sur-
gery, 6 PT), or other miscellaneous issues noted in the pub-
lications as a complication (Griffin study: 41 surgery, 0 PT).
Meta-analysis
All 3 RCTs reported improvement from baseline to follow-
up for both PT and surgery. Two studies (Griffin8 and
Palmer19) concluded that there were statistically signifi-
cant superior outcomes with surgery, while 1 study (Man-
sell15) concluded that there was no difference in outcome
between surgery and PT. For the primary outcome, differ-
ences in postintervention iHOT-33 scores were reported in
all 3 studies, and meta-analysis of the intention-to-treat
data demonstrated that the surgical group achieved a sig-
nificantly greater postintervention outcome compared with
the PT group (MD, 11.3; 95% CI, 1.9-20.7; P ¼ .046; I2 ¼
76.7%) (Figure 2). The as-treated analysis also demon-
strated greater postintervention outcomes in the surgery
group, with a slightly higher effect size (MD, 12.6; 95%
CI, 3.4-21.9; P ¼ .007; I2 ¼ 69.3%) (Figure 2).
For the secondary outcome, in the intention-to-treat meta-
analysis of the 2 studies (Palmer19 and Mansell15 studies)
reporting HOS-ADL and HOS-Sport, between-group postin-
tervention scores were not significantly different, although
favoring surgery over PT (HOS-ADL: MD, 3.9; 95% CI, –9.6 to
17.3; P¼ .571; I2¼ 85.1%; HOS-Sport: MD, 6.2; 95% CI, –6.8
to 19.2; P ¼ .347; I2 ¼ 71.1%) (Figure 3). In the as-treated
meta-analysis, the HOS-ADL showed a statistically
TABLE 3
Cochrane Collaboration Tool for Assessing Risk of Bias
Random Sequence
Generation
(Selection Bias)
Allocation
Concealment
(Selection Bias)
Blinding of
Participants and
Personnel
(Performance Bias)
Blinding of
Outcome
Assessment
(Detection Bias)
Incomplete
Outcome Data
(Attrition Bias)
Selective
Reporting
(Reporting
Bias)
Other
Bias
Palmer et al
(2019)19
Low Low High Low Low Low Low
Griffin et al
(2018)8
Low Low High Low Low Low Low
Mansell et al
(2018)15
Low Low High Low High Low High
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significant result of favoring surgery over PT (MD, 12.0;
95% CI, 7.5-16.5; P < .001; I2 ¼ 0%) (Figure 3). Adequate
data for as-treated analysis of HOS-Sport were not avail-
able. Additionally, adequate data for comparing the per-
centage achieving MCID were also not available.
DISCUSSION
In this meta-analysis of 3 RCTs including 650 patients with
FAI, surgical treatment resulted in significantly better
PROs than PT as assessed by iHOT-33 and HOS-ADL, with
the difference exceeding MCID values for each outcome.
This conclusion is consistent with the results of the 2
higher-quality, larger RCTs included in the current review
(Palmer19 and Griffin8 studies). The total cohort of 650 FAI
patients also allows for improved power relative to individ-
ual studies that may have been underpowered. While the
Mansell15 study concluded that no significant difference in
outcomes was present between surgery and PT, the results
of this RCT were influenced by several issues that may
have introduced bias. The most important of these issues
is a 70% crossover from PT to surgery, which resulted in the
intention-to-treat analysis comparing 2 groups in which the
majority of both groups had surgical intervention. In the
current meta-analysis, combining the intention-to-treat
analysis data for the iHOT-33 still demonstrated a signifi-
cant difference favoring surgery (despite the smallest effect
size present for the Mansell study). The as-treated analysis
of the HOS-ADL results demonstrated a statistically signif-
icant effect size, with the effect size being very similar
between the Mansell and Palmer studies (not available for
the Griffin study). It was not possible to report surgery-
specific or PT-specific effect sizes because the pre- to post-
intervention change was not reported in any of the studies,
only the difference in final PRO.
The collective results of these 3 research studies (all evi-
dence level 1) support the efficacy of surgical intervention
for FAI. However, the general difference between surgery
and PT was just slightly greater than established MCID
thresholds. MCID data were not routinely available across
all studies and, in some cases, used different values. Nwa-
chukwu et al16 defined the MCIDs for HOS-ADL, HOS-
Sport, and iHOT-33 to be 8.3, 14.5, and 12.1, respectively.
The Palmer19 study used an MCID of 9 for HOS-ADL, while
the Mansell15 study used MCIDs of 6 to 8, 8 to 9, and 12 for
HOS-ADL, HOS-Sport, and iHOT-33, respectively. On the
contrary, the Griffin8 study used an MCID of 6.1 for iHOT-33.
Figure 2. (A) Intention-to-treat meta-analysis of studies
reporting iHOT-33 (P ¼ .046). (B) As-treated meta-analysis
of studies reporting iHOT-33 (P ¼ .007). *Palmer19 did not
have as-treated data but provided the low crossover rate;
intention-to-treat was used in this analysis. ES, effect size;
iHOT-33, international Hip Outcome Tool–33.
Figure 3. (A) Intention-to-treat meta-analysis of studies
reporting HOS-ADL (P ¼ .571). (B) As-treated meta-analysis
of studies reporting HOS-ADL (P < .001). (C) Intention-to-
treat meta-analysis of studies reporting HOS-Sport (P ¼
.347). ADL, Activities of Daily Living; ES, effect size; HOS, Hip
Outcome Score.
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The Palmer study reported that 51% of patients undergoing
surgery and 32% of those undergoing PT reached the MCID
for iHOT-33 (MCID defined as 12 points). The studies also
clearly demonstrated variability in surgical outcomes
between studies and within studies. The Mansell study con-
cluded that “most patients perceived no improvement at
2 years.” On the contrary, the Palmer study concluded that
“blinded clinical assessments revealed a greater improve-
ment in range of hip flexion and discomfort in patients allo-
cated to arthroscopic surgery . . . patient reported outcome
measured also indicated superior outcomes in patients ran-
domized to arthroscopic surgery.” Surgical procedures were
variable across studies and differed in some ways from the
currently accepted standards of most surgeons treating FAI.
The Palmer study reported a 70% rate of labral repair, while
the Griffin study reported a 25% rate of labral repair. The
need for different components of the surgical procedure was
assessed preoperatively as well as intraoperatively at the
surgeon’s discretion, which contributed to some of the vari-
ability. None of the studies appeared to utilize capsular
closure, which is now commonly utilized by most surgeons
and appears to improve outcomes. Frank et al6 showed ear-
lier recovery and return to sport in patients with complete
capsular closure compared with partial closure at 2 years,
with 13% and 0% revision rates in the partial and complete
closure groups, respectively.
It should also be noted that patients enrolled in 2 of the
studies8,15 may have received some form of nonsurgical
care before study enrollment, which may have affected the
success of PT but does represent common clinical practice.
Additionally, some patients appeared to similarly improve
with PT. The Mansell15 study can be viewed from an
intention-to-treat perspective, but given the high crossover
rate, this can be somewhat misleading. In this military
population, 70% of patients in the PT arm were unsatisfied
enough to cross over to surgery. At final follow-up, the out-
comes of these patients appeared to be similar to those of
patients who pursued surgery from the onset, although
reoperation was much more common in the patients cross-
ing over from PT to surgery (12.5% vs 2.5%). Additionally,
as expected, the complication rate was generally higher in
all 3 studies in the surgical group, although the major com-
plication rate was still low. This supports the general con-
cept that equivalent outcomes of FAI surgery can be
achieved after a 3- to 6-month trial of nonoperative
treatment.
Despite the findings of this meta-analysis, it is essential
to continue investigation into both surgical and nonsurgical
FAI management to better understand which patients
are most likely to improve enough with PT to avoid sur-
gery. Future research to understand which patients fail
to benefit from surgical intervention will also be impor-
tant, for this was not explicitly described or stratified in
these 3 studies. It is possible that some patients may not
improve with either PT or surgical intervention. Identi-
fication of these patients’ characteristics would allow for
further understanding and reevaluation of the source of
pain in these patients. It is also imperative that both
treatment strategies are assessed over long-term
follow-up, as one of the fundamental goals of
intervention for symptomatic FAI is to delay the lifelong
progression of secondary hip osteoarthritis, which will
require long-term follow-up.
Research efforts to determine the best evidence-based
nonsurgical management for patients with FAI are ongo-
ing. The use of a systematic review and consensus panel to
determine current best practice for the conservative man-
agement offered in these RCTs is helpful, but it highlights
the need for more research rather than expert opinion to
guide management.5 Components of PT, which have
recently yielded positive outcomes, include task- and
sport-specific activity modification training,20 movement
pattern training,10 and trunk stabilization.1 Emerging evi-
dence suggests that nonsurgical FAI management also
needs to address coexisting sleep and behavioral health
impairments. Young hip patients report more insomnia and
anxiety than age-matched controls,21 and baseline psycho-
logical impairment is associated with worse postoperative
outcomes.25 Extra-articular myofascial-based therapies
such as manual release, dry needling, and trigger point
injections4,24 may be useful adjuncts to facilitate progress
with strengthening, movement pattern normalization, and
long-term functional improvement. The variability in PT-
led intervention highlights the need for better systematic
research into the nonsurgical treatment protocols for FAI.
The role of activity level also deserves further attention in
future research. Pennock et al20 found an 82% success rate
of a nonsurgical treatment protocol when alterations in
activity level were accepted by the patient (41% maintain-
ing same sport and level).
There are several limitations to the current review in
addition to those previously mentioned. First, even though
RCTs minimize bias and provide the strongest level of
evidence, many patients with FAI choose not to enroll in
RCTs. The differences between patients enrolling and
declining RCT participation are not well established but
may play a role in the generalizability of these results.
Second, because of the variety of PROs used in the studies,
we were only able to perform meta-analysis on 3 outcome
measures, and only the iHOT-33 could be compared across
all 3 studies. This highlights the importance of including
several PROs in RCTs, as otherwise no meta-analysis
would be feasible. Third, we were only able to perform
meta-analysis of the data presented in the published liter-
ature. In 1 case, we were able to clarify an important error
in the treatment effect that would have affected the meta-
analysis of the data. It was not possible to compare the
preintervention with the postintervention mean differ-
ences to better investigate the variability of the treatment
effect of surgery and PT across studies. Additionally,
patients in some studies had exposure to PT before the
study, which could potentially have increased the selec-
tion of patients who were unlikely to improve with PT.
Last, based on the limitations of the literature, only 3
studies were included in this meta-analysis. However,
650 patients were included in this study, improving the
power and overall generalizability and making it suitable
for meta-analysis, which clarifies the contradictory results
between these studies.
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CONCLUSION
This meta-analysis of 3 RCTs that compared short-term
outcomes of surgery versus PT in patients with FAI dem-
onstrated that surgery resulted in superior outcomes com-
pared with PT based on iHOT-33 and HOS-ADL. However,
PT also resulted in clinically meaningful improvements in
patients and did not appear to compromise surgical
outcomes.
REFERENCES
1. Aoyama M, Ohnishi Y, Utsunomiya H, et al. A prospective, random-
ized, controlled trial comparing conservative treatment with trunk sta-
bilization exercise to standard hip muscle exercise for treating
femoroacetabular impingement: a pilot study. Clin J Sport Med.
2019;29(4):267-275.
2. Bozic KJ, Chan V, Valone FH, Feeley BT, Vail TP. Trends in hip
arthroscopy utilization in the United States. J Arthroplasty. 2013;
28(8_suppl):140-143.
3. Clohisy JC, Kim Y-J. Introduction. J Am Acad Orthop Surg. 2013;21:
S1-S3.
4. Dommerholt J, Chou LW, Finnegan M, Hooks T. A critical overview of
the current myofascial pain literature—February 2019. J Bodyw Mov
Ther. 2019;23(2):295-305.
5. Enseki K, Harris-Hayes M, White DM, et al. Nonarthritic hip joint pain.
J Orthop Sports Phys Ther. 2014;44(6):A1-A32.
6. Frank RM, Lee S, Bush-Joseph CA, et al. Improved outcomes after
hip arthroscopic surgery in patients undergoing T-capsulotomy with
complete repair versus partial repair for femoroacetabular impinge-
ment: a comparative matched-pair analysis. Am J Sports Med. 2014;
42(11):2634-2642.
7. Griffin DR, Dickenson EJ, Wall PD, et al. Protocol for a multicentre,
parallel-arm, 12-month, randomised, controlled trial of arthroscopic
surgery versus conservative care for femoroacetabular impingement
syndrome (FASHIoN). BMJ Open. 2016;6(8):e012453.
8. Griffin DR, Dickenson EJ, Wall PDH, et al. Hip arthroscopy versus best
conservative care for the treatment of femoroacetabular impingement
syndrome (UK FASHIoN): a multicentre randomised controlled trial.
Lancet. 2018;391(10136):2225-2235.
9. Griffin DR, Dickenson EJ, Wall PDH, et al. The feasibility of conducting
a randomised controlled trial comparing arthroscopic hip surgery to
conservative care for patients with femoroacetabular impingement
syndrome: the FASHIoN feasibility study. J Hip Preserv Surg. 2016;
3(4):304-311.
10. Harris-Hayes M, Czuppon S, Van Dillen LR, et al. Movement-pattern
training to improve function in people with chronic hip joint pain: a
feasibility randomized clinical trial. J Orthop Sports Phys Ther. 2016;
46(6):452-461.
11. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collabora-
tion’s tool for assessing risk of bias in randomised trials. BMJ. 2011;
343:D5928.
12. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of inter-
ventions: template for intervention description and replication (TIDieR)
checklist and guide. BMJ. 2014;348:G1687.
13. Hunt D,Prather H, Harris HayesM, Clohisy JC. Clinicaloutcomes analysis
of conservative and surgical treatment of patients with clinical indications
of prearthritic, intra-articular hip disorders. PM R. 2012;4(7):479-487.
14. Mansell NS, Rhon DI, Marchant BG, Slevin JM, Meyer JL. Two-year
outcomes after arthroscopic surgery compared to physical therapy
for femoracetabular impingement: a protocol for a randomized clinical
trial. BMC Musculoskelet Disord. 2016;17:60.
15. Mansell NS, Rhon DI, Meyer J, Slevin JM, Marchant BG. Arthroscopic
surgery or physical therapy for patients with femoroacetabular
impingement syndrome: a randomized controlled trial with 2-year fol-
low-up. Am J Sports Med. 2018;46(6):1306-1314.
16. Nwachukwu BU, Fields K, Chang B, et al. Preoperative outcome
scores are predictive of achieving the minimal clinically important
difference after arthroscopic treatment of femoroacetabular impinge-
ment. Am J Sports Med. 2017;45(3):612-619.
17. Palmer AJ, Ayyar-Gupta V, Dutton SJ, et al. Protocol for the Femoro-
acetabular Impingement Trial (FAIT): a multi-centre randomised con-
trolled trial comparing surgical and non-surgical management of
femoroacetabular impingement. Bone Joint Res. 2014;3(11):321-327.
18. Palmer AJ, Thomas GE, Pollard TC, et al. The feasibility of performing
a randomised controlled trial for femoroacetabular impingement sur-
gery. Bone Joint Res. 2013;2(2):33-40.
19. Palmer AJR, Ayyar Gupta V, Fernquest S, et al. Arthroscopic hip
surgery compared with physiotherapy and activity modification for
the treatment of symptomatic femoroacetabular impingement: multi-
centre randomised controlled trial. BMJ. 2019;364:l185.
20. Pennock AT, Bomar JD, Johnson KP, Randich K, Upasani VV. Non-
operative management of femoroacetabular impingement: a pro-
spective study. Am J Sports Med. 2018;46(14):3415-3422.
21. Prather H, Creighton A, Sorenson C, et al. Anxiety and insomnia in
young and middle-aged adult hip pain patients with and without fem-
oroacetabular impingement and developmental hip dysplasia. PM R.
2018;10(5):455-461.
22. Schulz KF, Altman DG, Moher D; Group C. CONSORT 2010 State-
ment: updated guidelines for reporting parallel group randomized
trials. Open Med. 2010;4(1):e60-e68.
23. Slade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on
Exercise Reporting Template (CERT): explanation and elaboration
statement. Br J Sports Med. 2016;50(23):1428-1437.
24. Stecco A, Stern R, Fantoni I, De Caro R, Stecco C. Fascial disorders:
implications for treatment. PM R. 2016;8(2):161-168.
25. Stone AV, Malloy P, Beck EC, et al. Predictors of persistent post-
operative pain at minimum 2 years after arthroscopic treatment of
femoroacetabular impingement. Am J Sports Med. 2019;47(3):
552-559.
26. Wall PD, Dickenson EJ, Robinson D, et al. Personalised hip therapy:
development of a non-operative protocol to treat femoroacetabular
impingement syndrome in the FASHIoN randomised controlled trial.
Br J Sports Med. 2016;50(19):1217-1223.
27. Wall PD, Fernandez M, Griffin DR, Foster NE. Nonoperative treatment
for femoroacetabular impingement: a systematic review of the litera-
ture. PM R. 2013;5(5):418-426.
APPENDIX 1
SEARCH STRATEGY
The databases included Ovid Medline 1946-, Embase 1947-,
Scopus 1960-, Cochrane Central Register of Controlled
Trials, Cochrane Database of Systematic Reviews, and
ClinicalTrials.gov, and a randomized controlled trial filter was
used. In total, 819 results were exported and 340 duplicates
were removed, resulting in 479 final citations for review.
Ovid Medline
87 results on March 15, 2019
Exp Femoracetabular impingement/ OR “femoral acetabu-
lar”.mp. OR “femoro acetabular”.mp. OR “femoral acetabu-
lar”.mp. OR femoracetabular.mp. OR femoroacetabular.mp.
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OR (cam adj1 impingement).mp. OR (pincer adj1 impinge-
ment) .mp. OR (hip adj3 impingement).mp.
AND
(randomized controlled trial.pt. or double-blind method/
or controlled clinical trials as topic/ or randomized con-
trolled trials as topic/ or early termination of clinical trials
as topic/ or (randomized adj7 trial*).mp. or (randomised
adj7 trial*).mp. or (controlled adj3 trial*).mp. OR (double-
blind adj1 method).mp. or ((single or doubl* or tripl* or
treb*) and (blind* or mask*)).ti,ab,kw. or 4 arm.ti,ab,kw.
or four arm.ti,ab,kw.)
Embase
380 results on March 15, 2019
(‘Femoracetabular impingement’/exp OR ‘femoral acetabu-
lar’:ti,ab,kw,de OR ‘femoro acetabular’:ti,ab,kw,de OR ‘femoral
acetabular’:ti,ab,kw,de OR femoracetabular:ti,ab,kw,de OR
femoroacetabular:ti,ab,kw,de OR (cam NEAR/1 impingement):
ti,ab,kw,de OR (pincer NEAR/1 impingement):ti,ab,kw,de OR
(hip* near/3 impingement):ti,ab,kw,de)
AND
(‘randomized controlled trial’/exp OR (control near/3
group*):ti,ab,kw,de or ((patient or healthy or volunteer
or volunteers) NEAR/3 control*):ti,ab,kw,de or ‘controlled
clinical trial’:ti,ab,kw,de or ‘randomized controlled trial’:-
ti,ab,kw,de or ‘double-blind method’/exp or ‘controlled
clinical trials as topic’/exp or ‘randomized controlled trials
as topic’/exp or ‘early termination of clinical trials as topic’/
exp or (randomi?ed NEAR/7 trial*):ti,ab,kw,de or (double-
blind NEAR/1 method):ti,ab,kw,de or (controlled NEAR/3
trial*):ti,ab,kw,de or ((single or doubl* or tripl* or treb*)
and (blind* or mask*)):ti,ab,kw,de or ‘4 arm’:ti,ab,kw,de or
‘four arm’:ti,ab,kw,de)
Scopus
238 results on March 15, 2019
((TITLE-ABS-KEY (“femoral acetabular”)) OR (TITLE-
ABS-KEY (“femoro acetabular”)) OR (TITLE-ABS-KEY
(“femoral acetabular”)) OR (TITLE-ABS-KEY (femorace-
tabular)) OR (TITLE-ABS-KEY (femoroacetabular)) OR
(TITLE-ABS-KEY ((cam w/1 impingement)) OR (TITLE-
ABS-KEY (pincer w/1 impingement)) OR (TITLE-ABS-
KEY (hip w/3 impingement)))
AND ((TITLE-ABS-KEY ((patient OR healthy OR volun-
teer OR volunteers) W/3 control*)) OR (TITLE-ABS-KEY
(“controlled clinical trial”)) OR (TITLE-ABS-KEY
(“randomized controlled trial”)) OR (TITLE-ABS-KEY (ran-
domi?ed W/7 trial*)) OR (TITLE-ABS-KEY (“double-blind”
W/1 method)) OR (TITLE-ABS-KEY (controlled W/3 trial*))
OR (TITLE-ABS-KEY ((single OR doubl* OR tripl* OR
treb*) W/4 (blind* OR mask*))) OR (TITLE-ABS-KEY
(“4 arm”)) OR (TITLE-ABS-KEY (“four arm”)))
Cochrane
Cochrane Database of Systematic Review—1 result on
March 15, 2019
Cochrane Central Register of Controlled Trials—102
results on March 15, 2019
([mh “Femoracetabular impingement”] OR ((“femoro
acetabular” OR “femoral acetabular” OR Femoracetabular
OR Femoroacetabular OR cam OR pincer OR hip) near/1
impingement*):ti,ab,kw)
AND
(control*:ti,ab,kw OR trial*:ti,ab,kw OR blind*:ti,ab,kw
OR mask*:ti,ab,kw OR “double-blind”:ti,ab,kw OR
“4 arm”:ti,ab,kw OR “four arm”:ti,ab,kw)
ClinicalTrials.gov
11 results on March 15, 2019
physical therapy AND surgery AND femoracetabular
impingement [DISEASE]
APPENDIX 2
METHODOLOGICAL DETAILS
Two of the 3 studies included the following core components:
flexibility,8,15 core stability,8,19 and education to avoid the
impingement position.8,19 Additional core components
include hip joint mobilization,15 lumbar mobility,15 and
instruction in activity modification and physical activity.8
All studies allowed for individualization based on pain and
movement impairments. Additional nonoperative treat-
ments allowed included medications (nonsteroidal anti-
inflammatory medications) or corticosteroid injection,8
orthotics or taping,8 lumbar joint mobilization,15 and man-
ual therapy, including joint and soft tissue mobilization.8
Only 1 study8 specified items that were not allowed; Griffin
et al8 excluded interventions such as forceful manual tech-
niques into restricted range of motion, painful stretches that
had a hard end feel, acupuncture, electrotherapy, and hydro-
therapy. In contrast, a number of exercises included in the
treatment described by Mansell et al15 placed the involved
hip into the position of impingement. Patient adherence to
treatment session attendance was not reported in 2 stud-
ies,15,19 and no studies reported patient adherence to the
home exercise program. In the Griffin study, 30% of the
patients received treatment that was judged as low fidelity.
We used the CERT (Consensus on Exercise Reporting
Template) guidelines specifically to assist in scoring items
4 (what: procedures) and 8 (when and how much) in the
TIDieR (Template for Intervention Description and Repli-
cation) checklist. Two authors (M.T.S. and A.L.C.) indepen-
dently scored each item as “yes” or “no.” A “no” response
indicated that there was insufficient information provided
that would allow for replication. Disagreements were
resolved through discussion. Our assessments were based
on the information published in the article reporting trial
results, as well as all associated articles reporting the study
protocol, feasibility of the trial, and feasibility of the
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physical therapist–led treatment.26 Similarly, the same
guidelines were used to describe reporting of the surgical
treatments. The “yes” responses were summed to provide a
descriptive total representing the completeness of report-
ing for each article (Table A1).
TIDieR/CERT Assessment
Based on our review, no trial achieved 100% reporting of
the physical therapist–led treatment, unlike the surgical
treatment, which achieved near 67% to 92% (Table A1).
Griffin et al8 scored the highest with 67%, and Palmer
et al19 and Mansell et al15 each scored 33%. None of the
studies (or published protocols) reported sufficient detail
for the materials provided for the patient treatment and
physical therapist training, details about the procedures
included in treatment (exercise description, progression of
exercise, home exercise prescription, adherence), dosage of
the interventions (intensity, frequency, session time, dura-
tion), or specific guidelines for tailoring the interventions to
patients. Similarly, the quality of reporting of surgical
treatment details was also assessed, with each study
achieving 67% or greater.
TABLE A1
TIDiER Checklista
Study Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Totalb
Physical therapy
Palmer et al (2019)19 þ þ – – – þ þ – – – – – 4
Griffin et al (2018)8 þ þ – – þ þ þ – – þ þ þ 8
Mansell et al (2018)15 þ þ – – – þ þ – – – – – 4
Surgery
Palmer et al (2019)19 þ þ – – þ þ þ þ þ – – þ 8
Griffin et al (2018)8 þ þ þ þ þ þ þ þ þ – þ þ 11
Mansell et al (2018)15 þ þ þ þ þ þ þ þ þ – – þ 10
aItems: 1 ¼ name; 2 ¼ rationale; 3 ¼ materials; 4 ¼ procedures; 5 ¼ providers; 6 ¼ mode of delivery; 7 ¼ setting; 8 ¼ dose; 9 ¼ tailoring/
progression; 10 ¼ modifications; 11 ¼ planned fidelity; 12 ¼ actual fidelity. Consensus on Exercise Reporting Template (CERT) guidelines
were used to assist in scoring items 4 and 8. þ, yes; –, no.
bThe maximum score ¼ 12. Higher scores are more favorable.
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